Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis

Journal of Clinical Pathology - Tập 61 Số 3 - Trang 327-332 - 2008
Mangesh A. Thorat1, Caterina Marchiò2,3, Akira Morimiya1, Kay Savage3, Harikrishna Nakshatri4,5, Jorge S. Reis‐Filho3, S Badve6
1Department of Pathology and Laboratory Medicine, IU School of Medicine, Indianapolis, IN 46202, USA
2Department of Biomedical Science and Human Oncology, University of Turin, Turin, Italy
3Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
4Department of Biochemistry and Molecular Biology, IU School of Medicine, Indianapolis, IN 46202, USA
5Department of Surgery, IU School of Medicine, Indianapolis, IN 46202, USA
6Department of Pathology, Indiana University School of Medicine, 635 Barnhill Drive, MS-A128, Indianapolis, IN 46202, USA

Tóm tắt

Aims:Forkhead box A1 (FOXA1) is a forkhead family transcription factor expressed in breast cancer cells. It is essential for optimal expression of ∼50% of oestrogen receptor (ER)-related genes. This study explored the FOXA1 relationship with luminal and basal breast cancer subtypes, proliferation markers, and survival in breast cancer patients who had received similar treatment.Methods:A tissue microarray comprising tumours from 245 invasive breast cancer patients with 67 months of median follow-up was analysed for FOXA1 expression by immunohistochemistry. Interpretable FOXA1 expression, obtained in 184 patients, was analysed along with other variables such as tumour grade, size, nodal status, ER, progesterone receptor, HER2/neu, proliferation and basal markers.Results:FOXA1 expression (score >3) was seen in 139 of 184 breast cancers. It correlated positively with ERα (p<0.0001), progesterone receptor (p<0.0001), and luminal subtype (p<0.0001); negatively with basal subtype (p<0.0001), proliferation markers and high histological grade (p = 0.0327). Univariate analysis showed nodal status, tumour grade, ER, progesterone receptor, FOXA1, basal markers and p53 as significant predictors of overall survival. Multivariate analysis showed that only nodal status (p = 0.0006) and ER (p = 0.0017) were significant predictors of OS. In luminal subtype patient subgroup, FOXA1 expression was associated with better survival (p = 0.0284) on univariate analysis.Conclusion:Based on this study in patients treated with surgery followed by adjuvant anthracycline-based chemotherapy, FOXA1 expression is associated with good prognosis. It correlates with luminal subtype breast cancer, and could possibly serve as a clinical marker for luminal subtype A. Prognostic ability of FOXA1 in these low-risk breast cancers may prove to be useful in treatment decision making.

Từ khóa


Tài liệu tham khảo

10.1038/nrc721

10.1172/JCI27987

10.1016/S1470-2045(04)01413-5

Clarke, 1997, Dissociation between steroid receptor expression and cell proliferation in the human breast., Cancer Res, 57, 4987

10.1038/35021093

10.1073/pnas.191367098

10.1158/1078-0432.CCR-04-0220

10.1200/JCO.2005.03.2755

10.1016/S1043-2760(00)00271-X

10.1210/me.2005-0334

10.1074/jbc.M002726200

10.1016/j.mce.2004.02.021

10.1016/j.cell.2005.05.008

10.1073/pnas.0505575102

10.1038/sj.onc.1209415

10.1158/0008-5472.CAN-07-0746

10.1002/ijc.22389

10.1158/1078-0432.CCR-07-0122

10.1007/s10549-006-9492-5

10.1038/modpathol.3800542

10.1038/modpathol.3800621

10.1111/j.1365-2559.2006.02467.x

10.1101/gad.1446006

10.1016/S1097-2765(02)00459-8

10.1093/emboj/17.1.244

10.1016/j.cell.2006.09.048

10.1242/dev.01917

10.1210/en.143.6.2357

10.1046/j.1432-0436.1998.6250221.x

10.1023/B:JOMG.0000023584.01750.16

Thông tin
Thông tin xuất bản

Journal of Clinical Pathology

Tập 61 Số 3

327-332

Thông tin tác giả